Benzinga | May 3, 2021 04:06PM EDT

Ligand Pharmaceuticals Q1 EPS $1.41 Beats $1.12 Estimate, Sales $55.15M Miss $62.85M Estimate

Ligand Pharmaceuticals (NASDAQ:LGND) reported quarterly earnings of $1.41 per share which beat the analyst consensus estimate of $1.12 by 25.89 percent. This is a 58.43 percent increase over earnings of $0.89 per share from the same period last year. The company reported quarterly sales of $55.15 million which missed the analyst consensus estimate of $62.85 million by 12.25 percent. This is a 66.31 percent increase over sales of $33.16 million the same period last year.